Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Nov 21, 2023
Date Accepted: Apr 21, 2024

The final, peer-reviewed published version of this preprint can be found here:

Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study

Otten M, Djamei V, Augustin M

Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study

JMIR Dermatol 2024;7:e54762

DOI: 10.2196/54762

PMID: 39121470

PMCID: 11344180

Development, feasibility, and acceptability of the electronic Patient Benefit Index for Psoriasis in clinical practice

  • Marina Otten; 
  • Vahid Djamei; 
  • Matthias Augustin

ABSTRACT

Background:

Patient-reported outcomes are relevant in clinical practice showing patient benefits, supporting clinicians’ decision making and contributing to the delivery of high standards of care. Digital monitoring of PROs is still rare. The Patient Benefit Index (PBI) measures benefits and goals from patients’ views and may be relevant for regular documentation and for shared decision making.

Objective:

We aimed to develop electronic versions of the PBI to examine their feasibility and acceptability in clinical practice for patients with psoriasis.

Methods:

We developed an app and a web-version of the existing, valid PBI using focus groups and cognitive debriefings with patients before conducting a quantitative survey on its feasibility and acceptability. Conduction took part in an outpatient dermatology care unit in Germany. Descriptive and subgroup analyses were conducted.

Results:

139 patients completed the electronic PBIs and took part in the survey. The electronic PBI was understandable (92.8–98.6%) and feasible, e.g., easy to read (97.1%) and simple to handle (98.5%). Acceptability was also high, e.g.: Patients can imagine using and discussing the electronic PBI data in practice (65.5%) and documenting it regularly (63.3%). They believe it could support treatment decisions (84.9%) and improve communication with their physician (81.3%). They can imagine filling in electronic questionnaires regularly (84.9%) even preferring electronic over paper versions (81.2%). Older and less educated people show less feasibility, but the latter expected the relationship with their physician to improve and would be more willing to invest time or effort.

Conclusions:

The app and web-version of the PBI are usable and acceptable for patients offering comprehensive documentation and patient participation in practice. An implementation strategy should consider patient needs, their barriers, and facilitators, but also physicians’ attitudes and requirements from the healthcare system.


 Citation

Please cite as:

Otten M, Djamei V, Augustin M

Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study

JMIR Dermatol 2024;7:e54762

DOI: 10.2196/54762

PMID: 39121470

PMCID: 11344180

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.